Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An Oxford project using artificial intelligence to develop digital triage tools for mental health clinicians (CHRONOS) is one of 38 projects support by the second wave of the NHS AI Lab's AI in Health and Care Award.

Dr Andrey Kormilitzin, Department of Psychiatry, University of Oxford, said:

 

'CHRONOS will use AI technology to examine historical, anonymised medical notes to learn how care teams make decisions about treatment for individual patients. It will be capable of processing the long, detailed descriptions found in medical records to capture a “fingerprint” of an individual’s difficulties, symptoms and needs over time. CHRONOS will use this to suggest a treatment pathway alongside an explanation of its suggestion'.

The Award means that the NIHR Oxford Health Biomedical Research Centre (BRC) (a partnership between the University of Oxford and the Oxford Health NHS Foundation Trust) will be able to develop digital tools to make it easier for clinicians in secondary mental health care to rapidly identify the most appropriate treatments for their patients. This is the first time a mental health project has received the AI Award.

Professor Andrea Cipriani, PI on the project, Department of Psychiatry, University of Oxford, said:

 

'We are delighted to be one of the recipients of the Artificial Intelligence in Health and Care Award and look forward to developing CHRONOS to bring faster and more effective treatment to mental health patients in the NHS.'

The 38 trailblazing projects are backed by NHSX and the Accelerated Access Collaborative.

Health and Social Care Secretary, Matt Hancock, said:

 

'AI has the potential to completely revolutionise every part of how we approach healthcare, from how we diagnose diseases and the speed at which our doctors and nurses deliver treatments to how we support people’s mental health. The 38 projects we are backing reflect the UK’s trailblazing approach to innovation in the healthcare sector, and could help us take a leap forward in the quality of care and the speed of disease diagnoses and treatment in the NHS. Confronted with this global pandemic, our tech sector has risen to the challenge and upended how we do things through innovations to support people to test from home, complete remote consultations and diagnose issues safely.'

The Oxford project's team members include:

  • Professor Andrea Cipriani (Principal Investigator)
  • Dr Dan Joyce (Co-Investigator)
  • Dr Andrey Kormilitzin (Co-Investigator
  • Julia Harmer-Hunt (Patient and Public Involvement Co-Investigator)
  • Associate Professor Alejo Nevado-Holgado (Co-Investigator)
  • Dr Anthony James (Co-Investigator)

For more information about the NIHR Oxford Health BRC and to read the full press release.

Similar stories

Updating the circuit maps of the sympathetic neural network

A new review from Professor Ana Domingos’ lab and colleagues offers a fresh modern viewpoint on sympathetic neurons and their relation to immune cells and obesity.

Many adolescents game a lot without negative effects on their wellbeing

Although many school-age adolescents are spending considerable time gaming, it is not having a negative impact on their wellbeing.

Few mental health apps make it to real world, according to new Oxford University study

Despite enthusiasm for digital technology in addressing young people’s mental health, few effective apps have been successfully rolled out.

Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections

New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.